FDA Import Alerts for Food: Which Commodities Keep Getting Detained — and What That Tells You About Your Testing Gaps

FDA issues new import alerts quietly. There’s no press release, no phone call to your supplier. One week your shipment clears port in Los Angeles without incident; the next, it’s flagged under “Detention Without Physical Examination” — and you’re explaining a three-week delay to your retail buyer while your perishables sit in a cold storage warehouse running up fees.

Import alerts are one of FDA’s most consequential enforcement tools, and they’re not well understood outside the import community. Understanding which food categories trigger them most often, which contaminants keep showing up, and what the data tells you about sourcing risk is genuinely actionable intelligence. Whether you’re a food manufacturer, an ingredient importer, or a supplement brand buying raw botanicals overseas, this is a regulatory mechanism that should be shaping your supplier qualification process.

What an FDA Import Alert Actually Does (It’s Not Just a Single Detention)

A routine FDA detention is a one-time event. An import alert is structurally different — and far more disruptive. Once FDA issues an import alert for a specific firm, product category, or country of origin, it authorizes field offices nationwide to detain future shipments automatically, without physically examining them. The formal term is “Detention Without Physical Examination,” or DWPE. The practical effect is that your product gets flagged the moment it hits the FDA’s OASIS import tracking system, before a single inspector looks at a box.

There are currently more than 600 active import alerts across all FDA-regulated product categories. Food and food-related products account for a significant portion. Getting a firm removed from an import alert requires providing what FDA calls “competent evidence” — typically a series of clean, third-party laboratory results demonstrating the problem has been corrected. That process routinely takes six months minimum. Some firms have spent two to three years working through it.

FDA’s own data shows the agency physically examines fewer than 2% of food import line entries in any given year. That sounds like the odds favor importers. But the DWPE mechanism changes the calculus entirely: firms and commodities on active alerts face near-automatic detention regardless of how stretched FDA’s field staff is. The system is designed to be self-reinforcing — once you’re on the list, you stay on it until you can prove otherwise with documentation that will hold up to scrutiny.

The Commodities That Keep Showing Up on FDA’s Radar

Not all food categories carry equal import risk. A handful of commodities consistently generate the highest rates of refusal and import alert listings, and the reasons are worth understanding in detail.

Spices and seasoning blends sit near the top of almost every import refusal summary FDA publishes. The primary driver is Salmonella contamination. Dried spices can harbor the pathogen without any visible spoilage, and the low water activity that makes them shelf-stable also allows Salmonella to persist for months — sometimes longer — at ambient storage temperatures. FDA’s import alerts covering spices (including IA 28-09 and related alerts) span firms and countries across South Asia, East Africa, and beyond. The 2023–2024 wave of cinnamon-related enforcement actions brought additional scrutiny to this category, with some products flagged for elevated lead levels alongside microbial concerns. When a single commodity shows up in two separate enforcement streams — pathogen contamination and heavy metals — it’s a signal that testing protocols in the supply chain have meaningful gaps.

Seafood generates some of the highest absolute refusal volumes FDA records. The violation types span several categories: Salmonella, Listeria monocytogenes, decomposition and filth (insect fragments, parasites), and drug residues — particularly fluoroquinolone antibiotics and chloramphenicol in farmed shrimp and fish from Southeast Asia. These antimicrobial compounds are banned in US food animal production; FDA has zero tolerance for their presence in imported seafood. Import Alert 16-120 and associated alerts cover Salmonella in seafood from specific firms, while separate alerts address drug residues by country. For buyers sourcing shrimp, tilapia, or catfish from Vietnam, Indonesia, or Thailand, drug residue testing isn’t optional risk management — it’s table stakes.

Produce, particularly leafy greens, fresh herbs, and berries, draws attention primarily for Cyclospora cayetanensis, E. coli O157:H7, and pesticide residues exceeding EPA tolerances. The pesticide gap catches importers off guard repeatedly: compounds that are legally registered for use in the country of origin may not be permitted at the detected concentration under US law. Your supplier’s product can be fully compliant at the point of export and still get detained at the US border. That’s not a technicality — it’s a real liability that proactive residue screening before shipment can catch.

Dietary supplement raw ingredients, especially botanicals, protein concentrates, and herbal extracts sourced from China and India, appear regularly in import alerts related to adulteration with undeclared pharmaceutical compounds, heavy metals above acceptable daily intake thresholds, and microbial contamination. This risk doesn’t stay offshore. If your US-based contract manufacturer is sourcing raw materials from a firm on an active import alert, that regulatory exposure flows upstream directly into your finished product’s compliance status.

Country-of-Origin Patterns That Are Worth Knowing

FDA’s import alert database is publicly searchable at accessdata.fda.gov — by country, product type, reason code, and issuing date. A few patterns emerge when you look at the distribution over time.

China and India appear among the highest-volume import alert listings for food and supplement ingredients, which reflects in part that they supply an enormous share of US food and supplement imports overall. Raw alert counts correlate with import volume, so raw numbers need context. But specific compliance gaps are well-documented in FDA enforcement records: heavy metals in traditional herbal products, undeclared pharmaceutical adulteration in weight-loss and sexual enhancement supplements, and pesticide residues are recurring themes across multiple enforcement cycles.

Mexico’s fresh produce trade generates significant detention activity, particularly for peppers, cilantro, and melons tied to Cyclospora and Salmonella contamination clusters. Several outbreak investigations over the past three years have traced pathogens to specific growing regions and harvest operations in Mexico, leading to updated import sampling programs.

Vietnam and Indonesia appear consistently in seafood-related alerts, primarily for aquaculture drug residue issues. The specific compounds — fluoroquinolones, malachite green, nitrofurans — are the same ones FDA has been targeting for more than a decade, which tells you this isn’t a problem the industry has resolved.

For any brand actively sourcing from these regions, the import alert data isn’t a reason to change suppliers wholesale. It’s a reason to build a testing specification that maps directly to the known risk profile.

What Getting Put on an Import Alert Actually Costs

The direct financial exposure from a single detained shipment is substantial. Storage fees for perishables during FDA review, third-party laboratory re-testing required for release consideration, broker and legal costs, and potential destruction or re-exportation of non-conforming product add up quickly. For a detained container of seafood at a major US port, direct costs regularly run $15,000–$30,000 before you account for lost sales or replacement product.

But the indirect costs are typically larger and harder to recover from. Retailers and major buyers often suspend purchasing across an entire product line — not just the affected lot — when an import alert is triggered. Lead time disruptions cascade to retail shelf availability, and in category-managed retail environments, empty shelves during a review period can cost you shelf space you won’t get back easily. If the import alert involves a safety issue — Salmonella, undeclared allergens, heavy metals — FDA may escalate to a mandatory recall, layering regulatory response costs on top of the detention and storage expenses.

The reputational dimension has become increasingly acute. FDA import alert listings are public records. They appear in litigation databases, competitor intelligence searches, and increasingly in the due diligence workflows of large retail buyers. A buyer evaluating two comparable suppliers will see that import alert history.

How Proactive Testing Keeps You Off the List

The import alert system is fundamentally reactive. FDA detects a problem through surveillance sampling, documents it, and then creates friction for future shipments. Brands that test proactively — at the point of manufacture overseas or before an ingredient is accepted by a US contract manufacturer — can catch the same issues FDA would detect, but before the shipment is ever on the water.

The testing package needs to match the actual risk profile of the product. For spices and botanical ingredients, that means Salmonella and total aerobic plate count at minimum, plus targeted heavy metals analysis (lead, arsenic, cadmium, mercury) via ICP-MS. For seafood, drug residue screening via LC-MS/MS and comprehensive microbial panels covering Salmonella, Listeria, and Staphylococcus aureus are both necessary. For produce-derived ingredients, pesticide residue screening against EPA action levels and current FDA/Codex tolerances needs to be part of the specification.

For brands sourcing from countries or firms with documented import alert histories, working with food safety laboratories that hold ISO 17025 accreditation provides the most defensible documentation if you ever need to petition FDA for removal from an alert. Accreditation means the lab’s methods have been independently validated by a third-party assessor — the data will hold up under FDA review in a way that results from non-accredited facilities often won’t.

At Qalitex, we work regularly with ingredient buyers and contract manufacturers building supplier qualification programs specifically structured around FDA import risk — from initial lot-level testing to ongoing monitoring tied to active import alert status. The cost of a rigorous testing program is typically recovered within the first detained shipment it prevents.

Start With the Public Data You Already Have Access To

Before you finalize any new supplier relationship — particularly for spices, botanical extracts, seafood, or produce-derived ingredients — spend time in FDA’s import alert database. Search by country and product type. Look at the reason codes. Note whether violations are microbial, chemical, or adulteration-related.

What you find should directly shape your testing specifications. If a specific compound shows up repeatedly in FDA detentions for your commodity category, that compound needs to be in your lot release criteria. Not as a regulatory checkbox, but because the import alert data is FDA telling you, clearly, where the supply chain is failing.

The brands that consistently avoid import friction aren’t the ones hoping their suppliers are clean. They’re the ones verifying it before the shipment leaves the port of origin.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• Supplier Qualification and Raw Material Testing — Ayah Labs specializes in COA verification and incoming material testing for global ingredient suppliers.
• FDA Regulatory Consulting and Import Compliance Strategy — Aurora TIC helps manufacturers navigate FDA enforcement programs, including import alert response and remediation documentation.
• Canadian Food and Supplement Import Testing — Androxa provides Health Canada–compliant testing for products entering the Canadian market from international suppliers.